Shanxi Haoqijun Pharmaceutical

Shanxi Haoqijun Pharmaceutical is a China-based pharmaceutical company specializing in the research, development, and manufacturing of treatments for blood-related disorders. The company is best known for its focus on hematology, particularly in the application of integrated traditional Chinese and Western medicine to treat conditions such as aplastic anemia and immune thrombocytopenic purpura. Its flagship products include the Zaizhang Shengxue series, which are widely utilized in clinical settings across China. Founded by the hematology specialist Hao Qijun, the company operates integrated R&D and manufacturing facilities in Shanxi Province. It has historically been listed on China's New Third Board, reflecting its established position in the domestic specialty pharma market.